Evaluating the Value of the Genetic Risk Variants of Haem-Oxygenase-1, Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 in Prediction of the Pr - Egyptian Knowledge Bank

184538

Evaluating the Value of the Genetic Risk Variants of Haem-Oxygenase-1, Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 in Prediction of the Pr

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Genetic variants of vascular endothelial growth factor gene polymorphism affect the risk and severity of ischemic stroke: a case–control study

Article

Gene polymorphisms of the Vascular Endothelial Growth Factor (VEGF) in Promotor Region -2578 C/A and -460 T/C as a Risk Factor of Diabetic Retinopathy in Egyptian Patients with D

Article

Association of Single-Nucleotide Polymorphism (rs833061) of Vascular Endothelial Growth Factor with Breast Cancer Risk

Article

The genetic influence of VEGFA single nucleotide polymorphism (SNP) (rs1570360) on the risk, disease activity, and severity in systemic lupus erythematosus patients.

Article

Evaluation of Homocysteine and Plasminogen Activator Inhibitor-1 Changes in Age Related Macular Degeneration

Article

Association between Vascular Endothelial Growth Factor Gene +405 C/G Polymorphism and Acute Coronary Syndrome

Article

Study of Relationship between G894T Variant of Endothelial Nitric Oxide Synthase Gene and Acute Ischemic Stroke

Article

Relation between Endothelial Protein C Receptor Gene Polymorphism 6936A/G and the Risk of Vascular Access Thrombosis in Patients with End Stage Renal Disease on Hemodialysis

Article

Angiogenic and Placental factors as Predictors for Gestational Hypertensive Disorders: Which is appropriate?

Article

Allelic Polymorphism in the Endothelial Nitric Oxide Synthase Gene in Coronary Artery Diseases